Glenview adds Eli Lilly, AbbVie, trims CVS, AMAT, among top Q2 trades (LLY:NYSE)
· seekingalpha.com
Glenview Capital’s 13F reveals new Eli Lilly and AbbVie stakes, exits in DXC/ZoomInfo/Lithia, and big shifts in CVS, Meta, and Thermo Fisher—read now.
Glenview Capital Management took new equity positions in Eli Lilly (LLY), with nearly 58K shares, and AbbVie (ABBV), with ~149K shares, according to the hedge f...